107
Participants
Start Date
February 25, 2019
Primary Completion Date
January 21, 2022
Study Completion Date
June 28, 2024
Retifanlimab
INCMGA00012 administered at 500 milligrams (mg) by intravenous infusion once every 4 weeks
Fondazione Del Piemonte Per L'Oncologia Ircc Candiolo, Candiolo
Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin
Chu Hopital de La Timone, Marseille
Roswell Park Cancer Institute, Buffalo
University of Rochester Medical Center, Rochester
Upmc Cancercenter, Pittsburgh
Irccs Azienda Ospedaliera Universitaria San Martino, Genova
Georgetown University Hospital, Washington D.C.
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan
European Institute of Oncology, Milan
Elbe Klinikum Buxtehude, Buxtehude
Inova Fairfax Hospital, Fairfax
Universitatsklinikum Schleswig-Holstein, Kiel
West Virginia University Hospitals Inc, Morgantown
Hospital General Universitario Gregorio Maranon, Madrid
Universitatsklinikum Giessen Und Marburg Gmbh, Klinik Für Innere Medizin, Marburg
Iov - Istituto Oncologico Veneto Irccs, Padua
Norton Cancer Institute, Louisville
A.O.U. Di Modena - Policlinico, Modena
Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu, Nantes
Universitatsklinikum Essen, Essen
The Christ Hospital, Cincinnati
Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria Alle Scotte, Siena
Mayo Clinic Rochester, Rochester
Rush University, Chicago
Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari, Bari
Universitaetsklinikum in Tubingen, Tübingen
HOPITAL CHARLES NICOLLE CHU ROUEN - H�PITAL DE BOIS-GUILLAUME, Rouen
University of Colorado Cancer Center, Aurora
Istituto Nazionale Tumori Irccs Fondazione Pascale, Naples
H�PITAL AMBROISE PAR, Boulogne-Billancourt
University Hospital Regensburg, Regensburg
University of California San Francisco Comprehensive Cancer Center, San Francisco
Stanford Cancer Institute, Palo Alto
Institut Gustave Roussy, Villejuif
University of Washington - Seattle Cancer Care Alliance, Seattle
John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute of Nj, New Brunswick
St Vincent'S Hospital Sydney, Darlinghurst
Cross Cancer Institute, Edmonton
Tom Baker Cancer Centre, Calgary AB
London Health Sciences Centre Lhsc - South Street Hospital, London
Sir Mortimer B. Davis Jewish General Hospital Segal Cancer Ctr, Montreal
McGill University Health Centre/Glen Site/Cedars Cancer Centre, Montreal
Fakultni Nemocnice Olomouc, Olomouc
Prof Mudr Petr Arenberger Drsc Mba, Prague
Nemocnice Na Bulovce, Prague
Thomayerova Nemocnice, Praha 4-krc
CHU DE NICE - H�PITAL L'ARCHET 1, Nice
Hospital Saint Louis, Paris
Helios Klinikum Erfurt, Erfurt
National Institute of Oncology, Budapest
Debreceni Egyetem Klinikai Kozpon Belgyogy Klinika, Debrecen
Szte Borgyogyszati Es Allergologiai Klinika, Szeged
ONCOLOGIA � IDI IRCCS ISTITUTO DERMOPATICO DELL'IMMACOLATA, Rome
Centrum Onkologii - Instytut Im. Marii Sklodowskiej - Curie, Warsaw
Hospital General Universitario Vall D Hebron, Barcelona
Hospital Clinic I Provincial, Barcelona
Centre Hospitalier Universitaire Vaudois (Chuv), Lausanne
Universitatsspital Zurich, Zurich
Castle Hill Hospital, Cottingham
Royal Free London Nhs Foundation Trust, London
The Royal Marsden Nhs Foundation Trust, London
The Royal Marsden Nhs Foundation Trust - Sutton, Sutton
Royal Cornwall Hospital Truro Sunrise Centre, Truro
Lead Sponsor
Incyte Corporation
INDUSTRY